Enovis Corp (ENOV) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-07-03..
Quick ratio
Overview →Financial period ending 2026-07-03; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-07-03. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 612.05M USD | Liabilities, Current |
| Cash and equivalents | 12.56M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 441.85M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 601.66M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-07-03 | (m) | $612.05M | $12.56M | (m) | $441.85M | $601.66M | (m) |
| 2026-04-03 | (m) | $608.66M | $33.13M | (m) | $444.21M | $602.54M | (m) |
| 2025-12-31 | (m) | $598.47M | $36.39M | (m) | $442.79M | $584.38M | (m) |
| 2025-10-03 | (m) | $575.44M | $33.62M | (m) | $431.77M | $613.75M | (m) |
| 2025-07-04 | (m) | $568.18M | $44.07M | (m) | $453.70M | $628.22M | (m) |
| 2025-04-04 | (m) | $477.42M | $38.46M | (m) | $435.62M | $585.91M | (m) |
| 2024-12-31 | (m) | $529.00M | $48.17M | (m) | $407.03M | $547.12M | (m) |
| 2024-09-27 | (m) | $530.22M | $35.42M | (m) | $400.22M | $609.66M | (m) |
| 2024-06-28 | (m) | $518.00M | $35.00M | (m) | $394.74M | $615.04M | (m) |
| 2024-03-29 | (m) | $549.13M | $66.27M | (m) | $381.05M | $586.00M | (m) |
| 2023-12-31 | (m) | $369.61M | $36.19M | (m) | $291.48M | $468.83M | (m) |
| 2023-09-29 | (m) | $355.28M | $32.13M | (m) | $277.03M | $470.91M | (m) |
| 2023-06-30 | (m) | $353.67M | $32.49M | (m) | $298.98M | $453.90M | (m) |
| 2023-03-31 | (m) | $349.50M | $21.90M | (m) | $280.75M | $438.96M | (m) |
| 2022-12-31 | (m) | $565.20M | $24.30M | (m) | $267.38M | $426.64M | (m) |
| 2022-09-30 | (m) | $853.92M | $54.96M | (m) | $258.82M | $416.87M | (m) |
| 2022-07-01 | (m) | $812.80M | $95.61M | (m) | $255.20M | $400.85M | (m) |
| 2022-04-01 | (m) | $1.45B | $661.50M | (m) | $657.06M | $852.81M | (m) |
| 2021-12-31 | (m) | $1.02B | $719.37M | (m) | $638.70M | $776.29M | (m) |
| 2021-10-01 | (m) | $975.47M | $177.48M | (m) | $603.21M | $780.98M | (m) |
| 2021-07-02 | (m) | $899.42M | $62.31M | (m) | $599.88M | $663.54M | (m) |
| 2021-04-02 | (m) | $1.56B | $763.65M | (m) | $553.78M | $606.21M | (m) |
| 2020-12-31 | (m) | $811.66M | $97.07M | (m) | $517.01M | $564.82M | (m) |
| 2020-10-02 | (m) | $784.53M | $66.42M | (m) | $498.36M | $536.05M | (m) |
| 2020-07-03 | (m) | $758.73M | $66.40M | (m) | $449.67M | $556.71M | (m) |
| 2020-04-03 | (m) | $819.10M | $365.60M | (m) | $499.40M | $561.67M | (m) |
| 2019-12-31 | (m) | $857.31M | $109.63M | (m) | $561.87M | $571.56M | (m) |
| 2019-09-27 | (m) | $1.51B | $127.06M | (m) | $576.14M | $584.35M | (m) |
| 2019-06-28 | (m) | $1.60B | $131.93M | (m) | $616.26M | $594.80M | (m) |
| 2019-03-29 | (m) | $1.57B | $242.42M | (m) | $1.15B | $739.53M | (m) |
| 2018-12-31 | (m) | $1.20B | $245.02M | (m) | $989.42M | $496.54M | (m) |
| 2018-09-28 | (m) | $1.07B | $285.90M | (m) | $953.88M | $484.24M | (m) |
| 2018-06-29 | (m) | $1.07B | $257.70M | (m) | $986.27M | $490.16M | (m) |
| 2018-03-31 | (m) | $1.10B | $268.35M | (m) | $993.07M | $499.49M | (m) |
| 2017-12-31 | (m) | $1.10B | $262.02M | (m) | $970.20M | $429.63M | (m) |
| 2017-09-29 | (m) | $1.29B | $260.41M | (m) | $957.22M | $414.56M | (m) |
| 2017-06-30 | (m) | $1.15B | $272.23M | (m) | $978.61M | $454.60M | (m) |
| 2017-03-31 | (m) | $1.08B | $207.84M | (m) | $901.33M | $427.33M | (m) |
| 2016-12-31 | (m) | $1.11B | $221.73M | (m) | $913.61M | $403.86M | (m) |
| 2016-09-30 | (m) | $1.07B | $191.66M | (m) | $922.25M | $423.90M | (m) |
| 2016-07-01 | (m) | $1.09B | $184.67M | (m) | $906.34M | $432.25M | (m) |
| 2016-04-01 | (m) | $1.10B | $196.04M | (m) | $881.69M | $453.58M | (m) |
| 2015-12-31 | (m) | $1.12B | $197.47M | (m) | $888.17M | $420.39M | (m) |
| 2015-09-25 | (m) | $1.21B | $221.25M | (m) | $990.45M | $449.89M | (m) |
| 2015-06-26 | (m) | $1.20B | $212.21M | (m) | $1.02B | $447.31M | (m) |
| 2015-03-27 | (m) | $1.26B | $206.92M | (m) | $1.01B | $455.70M | (m) |
| 2014-12-31 | (m) | $1.29B | $305.45M | (m) | $1.03B | $442.73M | (m) |
| 2014-09-26 | (m) | $1.37B | $286.62M | (m) | $1.10B | $522.36M | (m) |
| 2014-06-27 | (m) | $1.42B | $333.97M | (m) | $1.15B | $569.20M | (m) |
| 2014-03-28 | (m) | $1.31B | $482.18M | (m) | $1.06B | $472.83M | (m) |
| 2013-12-31 | (m) | $1.38B | $311.30M | (m) | $1.03B | $445.75M | (m) |
| 2013-09-27 | (m) | $1.32B | $639.25M | (m) | $974.73M | $453.20M | (m) |
| 2013-06-28 | (m) | $1.25B | $587.94M | (m) | $933.71M | $467.27M | (m) |
| 2013-03-29 | (m) | $1.27B | $234.82M | (m) | $926.63M | $504.72M | (m) |
| 2012-12-31 | (m) | $1.18B | $482.45M | (m) | $873.38M | $493.65M | (m) |
| 2012-12-29 | (m) | (m) | $482.45M | (m) | (m) | (m) | (m) |
| 2012-09-28 | (m) | $1.22B | $517.34M | (m) | $882.87M | $519.36M | (m) |
| 2012-06-29 | (m) | $1.24B | $538.96M | (m) | $904.76M | $530.35M | (m) |
| 2012-03-30 | (m) | $1.20B | $579.93M | (m) | $873.80M | $555.39M | (m) |
| 2011-12-31 | (m) | $240.04M | $75.11M | (m) | $117.47M | $56.14M | (m) |
| 2011-12-29 | (m) | (m) | $75.11M | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | $212.03M | $64.45M | (m) | $104.79M | $79.18M | (m) |
| 2011-07-02 | (m) | (m) | $64.22M | (m) | (m) | (m) | (m) |
| 2011-07-01 | (m) | $205.23M | $64.22M | (m) | $103.31M | $78.56M | (m) |
| 2011-04-01 | (m) | (m) | $45.46M | (m) | (m) | (m) | (m) |
| 2011-01-03 | (m) | (m) | $60.54M | (m) | (m) | (m) | (m) |
| 2011-01-01 | (m) | (m) | $60.54M | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $191.51M | $60.54M | (m) | $98.07M | $57.94M | (m) |
| 2010-12-30 | (m) | (m) | $60.54M | (m) | (m) | (m) | (m) |
| 2010-10-01 | (m) | (m) | $42.78M | (m) | (m) | (m) | (m) |
| 2010-07-02 | (m) | (m) | $62.97M | (m) | (m) | (m) | (m) |
| 2010-01-02 | (m) | (m) | $49.96M | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | $49.96M | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | $28.76M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |